CSPI urges FDA to reverse course of bioterrorism rules
Tough new bioterrorism rules that entered into force earlier this month have come under fire from a US consumer watchdog, accusing the FDA of 'watering down' the rules.
News, Analysis & Insights on Nutrition, Supplements, and Health
Tough new bioterrorism rules that entered into force earlier this month have come under fire from a US consumer watchdog, accusing the FDA of 'watering down' the rules.
New Jersey-based Bradley Pharmaceuticals is to market a new probiotic product, supplied by Danish probiotics leader Chr. Hansen, to the North American physicians market.